{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:38:35Z","timestamp":1761892715210,"version":"3.44.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ahj.2005.03.006","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T13:46:10Z","timestamp":1141220770000},"page":"633-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical trial issues in weight-loss therapy"],"prefix":"10.1016","volume":"151","author":[{"given":"Manesh R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Califf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.03.006_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","article-title":"Overweight and obesity in the United States: prevalence and trends, 1960-1994","volume":"22","author":"Flegal","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"year":"1996","series-title":"Draft guidance for the clinical evaluation of weight-control drugs","key":"10.1016\/j.ahj.2005.03.006_bib2"},{"key":"10.1016\/j.ahj.2005.03.006_bib3","first-page":"42","article-title":"Natural hazards. Tonic or toxic? Americans are gobbling up nature's remedies for everything from obesity to depression","volume":"12","author":"Spake","year":"2001","journal-title":"US News World Rep"},{"key":"10.1016\/j.ahj.2005.03.006_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.99.2.198","article-title":"Good news for experimental concept but bad news for clinically effective therapy","volume":"99","author":"Reimer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.006_bib5","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1001\/jama.284.23.3036","article-title":"Contraindicated use of cisapride: impact of food and drug administration regulatory action","volume":"284","author":"Smalley","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.006_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jama.1991.03470020057032","article-title":"The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study","volume":"266","author":"Lauer","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.006_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.006_bib8","first-page":"S27","article-title":"Metabolic disruptions in the adipocyte-hepatocyte fatty acid axis as causes of hyperapo-B","volume":"19","author":"Sniderman","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.006_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/oxfordjournals.aje.a115686","article-title":"Weight as a risk for clinical diabetes in women","volume":"132","author":"Colditz","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2005.03.006_bib10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0026-0495(90)90164-8","article-title":"Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1","volume":"39","author":"Landin","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.ahj.2005.03.006_bib11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.006_bib12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1056\/NEJM199003293221303","article-title":"A prospective study of obesity and risk of coronary heart disease in women","volume":"322","author":"Manson","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib14","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1001\/jama.284.23.3047","article-title":"Drug labeling revisions\u2014guaranteed to fail?","volume":"284","author":"Woosley","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.006_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0005-7916(88)90038-9","article-title":"The operant side of behavior therapy","volume":"19","author":"Skinner","year":"1988","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"10.1016\/j.ahj.2005.03.006_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00844268","article-title":"Limitations of behavioral treatment of obesity: review and analysis","volume":"4","author":"Foreyt","year":"1981","journal-title":"J Behav Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1037\/0022-006X.52.3.480","article-title":"Effect of a multicomponent maintenance program on long-term weight loss","volume":"52","author":"Perri","year":"1984","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.ahj.2005.03.006_bib18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00014","article-title":"Evidence for success of behavior modification in weight loss and control","volume":"119","author":"Foreyt","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jama.279.11.839","article-title":"Sodium restriction and weight loss in the treatment of hypertension in older persons: a randomized controlled Trial Of Nonpharmacologic interventions in the Elderly (TONE). TONE Collaborative Research Group","volume":"279","author":"Whelton","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.006_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/8.suppl_B.57","article-title":"Obesity and hypertension: epidemiological and clinical issues","volume":"8","author":"MacMahon","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.03.006_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0021-9150(93)90042-S","article-title":"Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors","volume":"103","author":"Hellenius","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2005.03.006_bib22","first-page":"743","article-title":"A seven-year follow-up of a weight reduction programme in Finnish primary health care","volume":"46","author":"Karvetti","year":"1992","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.006_bib23","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/diacare.20.10.1503","article-title":"A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects","volume":"20","author":"Agurs-Collins","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.03.006_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1381\/096089297765555719","article-title":"A decade of change in obesity surgery. National Bariatric Surgery Registry (NBSR) Contributors","volume":"7","author":"Mason","year":"1997","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.006_bib26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-115-12-956","article-title":"NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel","volume":"115","author":"Anonymous","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1381\/096089299765553647","article-title":"Complications following Swedish adjustable gastric banding: a long-term follow-up","volume":"9","author":"Forsell","year":"1999","journal-title":"Obes Surg"},{"key":"10.1016\/j.ahj.2005.03.006_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00000658-199509000-00011","article-title":"Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus","volume":"222","author":"Pories","year":"1995","journal-title":"Ann Surg"},{"year":"1998","series-title":"Xenica\u00a0(orlistat) new drug application","key":"10.1016\/j.ahj.2005.03.006_bib29"},{"key":"10.1016\/j.ahj.2005.03.006_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/ajcn\/69.3.366","article-title":"Report of a National Institutes of Health\u2013Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons","volume":"69","author":"Yanovski","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ahj.2005.03.006_bib31","unstructured":"National Institutes of Health. RFA KD 98-019. Study of Health Outcomes of Weight-loss (SHOW). Release date: November 18, 1998. Available at http:\/\/grants2.nih.gov\/grants\/guide\/rfa-files\/RFA-DK-98-019.html. [accessed March 18, 2004]."},{"key":"10.1016\/j.ahj.2005.03.006_bib32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.CIR.0000023260.78078.BB","article-title":"Principles from clinical trials relevant to clinical practice: part I","volume":"106","author":"Califf","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.006_bib33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jama.1997.03540380025012","article-title":"Update: prevalence of overweight among children, adolescents, and adults\u2014United States, 1988-1994","volume":"277","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.006_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00005768-199911001-00004","article-title":"The obesity epidemic in children and adults: current evidence and research issues","volume":"31","author":"Flegal","year":"1999","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ahj.2005.03.006_bib36","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJM199106273242602","article-title":"Variability of body weight and health outcomes in the Framingham population","volume":"324","author":"Lissner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00024","article-title":"Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial","volume":"119","author":"Blair","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-128-7-199804010-00004","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases","volume":"128","author":"Bennett","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib39","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/archinte.159.21.2524","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention","volume":"159","author":"Bennett","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib40","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel","volume":"342","author":"Bennett","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib41","doi-asserted-by":"crossref","first-page":"903","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00013","article-title":"Diet-drug debacle","volume":"129","author":"Parisi","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.ijo.0800920","article-title":"Synergistic interactions between fenfluramine and phentermine","volume":"23","author":"Wellman","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.ahj.2005.03.006_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00006534-200101000-00069","article-title":"Serotonin syndrome: potential consequences of Meridia combined with Demerol or fentanyl","volume":"107","author":"Giese","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ahj.2005.03.006_bib44","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0002-9343(98)00370-2","article-title":"Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis","volume":"106","author":"Khurana","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib46","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0140-6736(79)91791-4","article-title":"Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin","volume":"1","author":"Lee","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.03.006_bib47","doi-asserted-by":"crossref","unstructured":"Mersfelder TL. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications. Cleve Clin J Med 2001;68:208\u20139, 213\u20139, 223.","DOI":"10.3949\/ccjm.68.3.208"},{"key":"10.1016\/j.ahj.2005.03.006_bib48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(99)03190-6","article-title":"Are drugs within a class interchangeable?","volume":"354","author":"Furberg","year":"1999","journal-title":"Lancet"},{"year":"1996","series-title":"Meridia (sibutramine hydrochloride monohydrate) new drug application 20-632","key":"10.1016\/j.ahj.2005.03.006_bib49"},{"key":"10.1016\/j.ahj.2005.03.006_bib50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized control trial","volume":"281","author":"Davidson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.03.006_bib51","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","article-title":"Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial","volume":"160","author":"McMahon","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mhj.2001.117510","article-title":"Effects of sibutramine on body weight and serum lipids: a double blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia","volume":"142","author":"Dujovne","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.03.006_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1067\/mhj.2001.117511","article-title":"Pounds of prevention: obesity therapy","volume":"142","author":"Patel","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.03.006_bib54","first-page":"34","article-title":"Drug treatment of obesity and type 2 diabetes","volume":"26","author":"Ziegler","year":"2000","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ahj.2005.03.006_bib55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199509143331101","article-title":"Body weight and mortality among women","volume":"333","author":"Manson","year":"1995","journal-title":"N Engl J Med"},{"year":"2000","series-title":"Rezulin to be withdrawn from the market","key":"10.1016\/j.ahj.2005.03.006_bib56"},{"year":"1998","series-title":"Roche announces voluntary withdrawal of Posicor","key":"10.1016\/j.ahj.2005.03.006_bib57"},{"key":"10.1016\/j.ahj.2005.03.006_bib58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199608293350910","article-title":"Pharmacotherapy for obesity\u2014do the benefits outweigh the risks?","volume":"335","author":"Manson","year":"1996","journal-title":"N Engl J Med"},{"year":"2001","series-title":"Phases of product development","author":"Wierenga","key":"10.1016\/j.ahj.2005.03.006_bib60"},{"key":"10.1016\/j.ahj.2005.03.006_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.006_bib62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/j.1550-8528.1994.tb00108.x","article-title":"Towards prevention of obesity: research directions","volume":"2","year":"1994","journal-title":"Obes Res"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305002528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305002528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:27:25Z","timestamp":1757568445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305002528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0002870305002528"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.006","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical trial issues in weight-loss therapy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}